| Home > Ärzte / Wissenschaftler > Forschungsschwerpunkte - Forschungscenter > Cardiovascular Research Center (CVRC) > Publikationen
Jacobi J, Maas R, Cordasic N, Koch K, Schmieder RE, Böger RH, Hilgers KF.
Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice.
Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H1058-66. Epub 2007 Dec 21.
Maas R, Schwedhelm E, Kahl L, Li H, Benndorf R, Lüneburg N, Förstermann U, Böger RH.
Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia.
Clin Chem. 2008 Feb;54(2):292-300. Epub 2007 Dec 10.
Maas R, Dentz L, Schwedhelm E, Thoms W, Kuss O, Hiltmeyer N, Haddad M, Klöss T, Standl T, Böger RH.
Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
Crit Care Med. 2007 Aug;35(8):1876-81.
Böger GI, Rudolph TK, Maas R, Schwedhelm E, Dumbadze E, Bierend A, Benndorf RA, Böger RH.
Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
J Am Coll Cardiol. 2007 Jun 12;49(23):2274-82. Epub 2007 May 25.
Maas R, Schulze F, Baumert J, Löwel H, Hamraz K, Schwedhelm E, Koenig W, Böger RH.
Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data.
Clin Chem. 2007 Apr;53(4):693-701. Epub 2007 Feb 22.
